TOGETHER Trial, a research consortium that studies the use of existing drugs as treatments for diseases, produced one of the most significant studies labeling ivermectin ineffective at reducing ...

A recent study published in the Journal of American Medical Association (JAMA) evaluated the effect of ivermectin on time to recovery from coronavirus disease 2019 (COVID-19) in patients with mild to ...

For anti-vaccine activists, the clinical trial results couldn’t have been better. The drug ivermectin, scientists in Argentina announced last year, prevented 100% of COVID-19 infections. That glowing ...

The controversial drug ivermectin failed in a large U.S. trial to reduce COVID-19 hospitalizations and deaths, but a University of Minnesota co-investigator said it warrants continued study because it ...

The antiparasitic drug ivermectin was found to show no signs of alleviating symptoms of coronavirus infection, according to a large clinical trial published on Wednesday in the New England Journal of ...

A study of more than 1,500 adults with mild to moderate COVID-19 infections found ivermectin did not significantly shorten illness duration when compared to a placebo. The research, published Oct. 21 ...

Ivermectin, an anti-parasitic drug popularized as a way to treat COVID-19 at home despite warnings from the Food and Drug Administration, was not shown to have a meaningful effect in shortening ...

Ivermectin, an anti-parasitic drug that has gained popularity as an alternative COVID-19 remedy despite warnings from federal health officials, does not shorten COVID-19 symptoms or reduce the rate of ...

A new study throws what may be the final bucket of cold water on the idea of ivermectin as a treatment for COVID-19. "There was no significant benefit in our primary endpoint of resolution of symptoms ...

(Gray News) - A recent study conducted in Brazil found that ivermectin, a medication used to treat certain parasitic infections, didn’t reduce the risk of hospitalization from COVID-19. The study was ...